logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
06/11/2025
Antoma Corporation: A loss of $0.040 per share in the second quarter; Net revenue of $1.33 billion in the second quarter, estimated at $1.31 billion; Inventory of $1.04 billion in the second quarter, estimated at $1.11 billion.
Latest
2 m ago
Cameroon's elected President Paul Biya was sworn in.
2 m ago
The CEO of Rheinmetall stated that the joint venture with ICEYE in space may sign its first contract within 4 weeks.
4 m ago
CEO of Rheinmetall Group: We will release the latest news on naval business opportunities at the Capital Market Day.
4 m ago
Dogwood Therapeutics (DWTX.US) reported revenue of 0 US dollars in Q3 2025, the same as the previous value; earnings per share were -8.20 US dollars, compared to -2.05 US dollars in the previous period, and the expected value was -1.44 US dollars.
4 m ago
US stock surged | AstraZeneca (AZN.US) rises more than 4% in pre-market trading, Q3 core earnings per share exceed expectations
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.